In vitro antifungal activity of DNA topoisomerase inhibitors.

Steverding, D, Evans, P, Msika, L, Riley, B, Wallington, J and Schelenz, S (2012) In vitro antifungal activity of DNA topoisomerase inhibitors. Medical Mycology, 50 (3). pp. 333-336. ISSN 1369-3786

Full text not available from this repository. (Request a copy)

Abstract

In this paper we report the results of the study of the in vitro effect of eight anticancer DNA topoisomerase inhibitors on the growth of Aspergillus fumigatus, A. niger, Candida glabrata and Cryptococcus neoformans. Only one compound, idarubicin, displayed promising antifungal activity against A. niger, C. glabrata and C. neoformans with MIC(50) values varying between 3.6 and 14.2 µM (1.8-7.1 µg/ml). Three other compounds, aclarubicin, doxorubicin and mitoxantrone, showed some antifungal activity against C. glabrata and C. neoformans with MIC(50) values in the mid micromolar range. The data of this study indicate that selected DNA topoisomerase inhibitors are a promising class of compounds for the development of new antifungal agents.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
University of East Anglia > Faculty of Medicine and Health Sciences > Research Groups > Medical Microbiology
Related URLs:
Depositing User: Deborah Clemitshaw
Date Deposited: 27 Mar 2013 20:45
Last Modified: 25 Jul 2018 03:20
URI: https://ueaeprints.uea.ac.uk/id/eprint/42028
DOI: 10.3109/13693786.2011.609186

Actions (login required)

View Item